(Q67720581)

English

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy

scientific article published on January 15, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

author name string

A. U. Buzdar

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

S. W. Kau

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

G. N. Hortobagyi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

F. C. Ames

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

F. A. Holmes

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

G. Fraschini

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

V. Hug

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

R. L. Theriault

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

M. D. McNeese

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

S. E. Singletary

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728373

10 November 2022

language of work or name

0 references

publication date

1 January 1992

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

15 January 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1728373

10 November 2022

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

69

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

448-452

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

1

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure

3

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer a prospective randomized trial

8

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs

9

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

11

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base

12

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancer

13

1 reference

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C448::AID-CNCR2820690229%3E3.0.CO;2-K

10 November 2022

Identifiers

10.1002/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728373%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67720581&oldid=1768337041"